{"id":"https://openalex.org/W1513401887","doi":"https://doi.org/10.3233/jad-2012-120805","title":"Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study","display_name":"Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study","alternate_titles":[],"publication_year":2012,"publication_date":"2012-12-03","ids":{"openalex":"https://openalex.org/W1513401887","doi":"https://doi.org/10.3233/jad-2012-120805","mag":"1513401887","pmid":"https://pubmed.ncbi.nlm.nih.gov/22936007"},"language":"en","primary_location":{"id":"doi:10.3233/jad-2012-120805","doi":"https://doi.org/10.3233/jad-2012-120805","is_oa":false,"landing_page_url":"https://doi.org/10.3233/jad-2012-120805","pdf_url":null,"source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1513401887"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110411232","display_name":"Teodoro del Ser","orcid":"https://orcid.org/0000-0001-9806-7083","observed_orcids":["https://orcid.org/0000-0001-9806-7083"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teodoro del Ser","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111433512","display_name":"K.-C. Steinwachs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210103859","display_name":"Institut f\u00fcr Psychogerontologie","ror":"https://ror.org/01b2pxy75","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210103859"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus C. Steinwachs","raw_affiliation_strings":["Institute of Psychogerontology, University Erlangen-Nuremberg, N\u00fcemberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Psychogerontology, University Erlangen-Nuremberg, N\u00fcemberg, Germany","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210103859"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113531458","display_name":"Hermann\u2010Josef Gertz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I926574661","display_name":"Leipzig University","ror":"https://ror.org/03s7gtk40","country_code":"DE","type":"education","lineage":["https://openalex.org/I926574661"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hermann J. Gertz","raw_affiliation_strings":["Memory Clinic, Department of Psychiatry, University of Leipzig, Leipzig, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memory Clinic, Department of Psychiatry, University of Leipzig, Leipzig, Germany","institution_ids":["https://openalex.org/I926574661"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108393641","display_name":"Mar\u00eda V. Andr\u00e9s","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mar\u00eda V. Andr\u00e9s","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004808977","display_name":"Bel\u00e9n G\u00f3mez\u2010Carrillo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bel\u00e9n G\u00f3mez-Carrillo","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049857345","display_name":"Miguel Medina","orcid":"https://orcid.org/0000-0002-7016-5340","observed_orcids":["https://orcid.org/0000-0002-7016-5340"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miguel Medina","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110127839","display_name":"Joan Albert Vericat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joan A. Vericat","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pilar Redondo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pilar Redondo","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109121440","display_name":"David Fleet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Fleet","raw_affiliation_strings":["Statistical Consultant, Data Magik Ltd., London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Consultant, Data Magik Ltd., London, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110084954","display_name":"Teresa Le\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teresa Le\u00f3n","raw_affiliation_strings":["Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Director, Medical Department, Noscira SA, Madrid, Tres Cantos, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.2622,"has_fulltext":false,"cited_by_count":359,"citation_normalized_percentile":{"value":0.98214068,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"33","issue":"1","first_page":"205","last_page":"215"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tideglusib","display_name":"tideglusib","score":0.8870000243186951},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9279999732971191}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.737376868724823},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7179627418518066},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.695135772228241},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6819961071014404},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5841092467308044},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49434971809387207},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.4585748314857483},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.4482356905937195},{"id":"https://openalex.org/C2776760841","wikidata":"https://www.wikidata.org/wiki/Q5550831","display_name":"Geriatric Depression Scale","level":4,"score":0.43653079867362976},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43513625860214233},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.43346548080444336},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.41752147674560547},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.35430872440338135},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2610716223716736},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.1889978051185608},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1876659393310547},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09564149379730225},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C3019858935","wikidata":"https://www.wikidata.org/wiki/Q4340209","display_name":"Depressive symptoms","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013830","descriptor_name":"Thiadiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D038362","descriptor_name":"Glycogen Synthase Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D038362","descriptor_name":"Glycogen Synthase Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3233/jad-2012-120805","doi":"https://doi.org/10.3233/jad-2012-120805","is_oa":false,"landing_page_url":"https://doi.org/10.3233/jad-2012-120805","pdf_url":null,"source":{"id":"https://openalex.org/S25155249","display_name":"Journal of Alzheimer s Disease","issn_l":"1387-2877","issn":["1387-2877","1875-8908"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318577","host_organization_name":"IOS Press","host_organization_lineage":["https://openalex.org/P4310318577"],"host_organization_lineage_names":["IOS Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's Disease","raw_type":"journal-article"},{"id":"pmid:22936007","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22936007","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Alzheimer's disease : JAD","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W38098989","https://openalex.org/W98709945","https://openalex.org/W1485363052","https://openalex.org/W1521960328","https://openalex.org/W1532078866","https://openalex.org/W1544359545","https://openalex.org/W1567624342","https://openalex.org/W1577837690","https://openalex.org/W1847168837","https://openalex.org/W1893185987","https://openalex.org/W1971859296","https://openalex.org/W1978063188","https://openalex.org/W1993174592","https://openalex.org/W1995377960","https://openalex.org/W2014346868","https://openalex.org/W2023215882","https://openalex.org/W2024719735","https://openalex.org/W2029898167","https://openalex.org/W2035167862","https://openalex.org/W2037053607","https://openalex.org/W2039140744","https://openalex.org/W2049146362","https://openalex.org/W2054183594","https://openalex.org/W2058063216","https://openalex.org/W2063120457","https://openalex.org/W2071686660","https://openalex.org/W2079472896","https://openalex.org/W2103708669","https://openalex.org/W2114358785","https://openalex.org/W2114729479","https://openalex.org/W2131943911","https://openalex.org/W2156220037","https://openalex.org/W2171772496","https://openalex.org/W3215125900"],"related_works":["https://openalex.org/W2112888438","https://openalex.org/W1522284801","https://openalex.org/W4252213574","https://openalex.org/W2142975609","https://openalex.org/W2946943842","https://openalex.org/W2125726293","https://openalex.org/W4238307970","https://openalex.org/W4322012059","https://openalex.org/W7117301776"],"abstract_inverted_index":{"This":[0,198],"pilot,":[1],"double-blind,":[2],"placebo-controlled,":[3],"randomized,":[4],"escalating":[5,36,226],"dose":[6],"trial":[7,234],"explored":[8],"the":[9,65,167,186,192,209,229],"safety":[10,66,204],"and":[11,55,67,95,118,126,151,188,205,228],"efficacy":[12,206],"of":[13,17,43,69,133,182,211,244],"tideglusib,":[14,215],"an":[15],"inhibitor":[16,32],"glycogen":[18],"synthase":[19],"kinase-3,":[20],"in":[21,116,136,147,156,161,166,185,191,219,246],"Alzheimer's":[22,83],"disease":[23],"(AD)":[24],"patients.":[25],"Thirty":[26],"mild-moderate":[27],"AD":[28,212],"patients":[29,213],"on":[30],"cholinesterase":[31],"treatment":[33,210],"were":[34,102,113,163],"administered":[35],"doses":[37,227],"(400,":[38],"600,":[39],"800,":[40],"1,000":[41],"mg)":[42],"tideglusib":[44,70,245],"or":[45,77,240],"placebo":[46,119],"(ratio":[47],"2":[48],":":[49],"1)":[50],"for":[51,74,122,208],"4,":[52,53],"6,":[54],"6":[56,137],"weeks,":[57],"respectively.":[58],"The":[59],"primary":[60],"objective":[61],"was":[62,108],"to":[63,176,196,225,238],"evaluate":[64],"tolerability":[68],"with":[71,214],"strict":[72],"criteria":[73],"drug":[75],"escalation":[76],"withdrawal.":[78],"Mini-Mental":[79],"Status":[80],"Examination":[81],"(MMSE),":[82],"Disease":[84],"Assessment":[85,100],"Scale-cognitive":[86],"subscale":[87],"(ADAS-cog+),":[88],"word":[89],"fluency,":[90],"Geriatric":[91],"Depression":[92],"Scale":[93],"(GDS),":[94],"a":[96,180,220,242],"final":[97],"Global":[98],"Clinical":[99],"(GCA)":[101],"assessed":[103],"as":[104,114],"secondary":[105],"objectives.":[106],"Treatment":[107],"well":[109],"tolerated.":[110],"Adverse":[111],"events":[112],"frequent":[115],"active":[117,138,168],"groups,":[120],"except":[121],"some":[123],"moderate,":[124],"asymptomatic,":[125],"fully":[127],"reversible":[128],"increases":[129],"(>2.5":[130],"\u00d7":[131],"ULN)":[132],"serum":[134],"transaminases":[135],"cases":[139],"(p":[140,170],"=":[141,171],"0.001).":[142],"Tideglusib":[143],"produced":[144],"positive":[145],"trends":[146],"MMSE,":[148],"ADAS-cog,":[149],"GDS,":[150],"GCA":[152],"without":[153],"statistical":[154],"significance":[155],"this":[157,233],"small":[158,199,230],"sample.":[159],"Responders":[160],"MMSE":[162,187],"significantly":[164],"higher":[165],"group":[169],"0.05).":[172],"Patients":[173],"escalated":[174],"up":[175],"1000":[177],"mg/day":[178],"had":[179],"benefit":[181,243],"1.68":[183],"points":[184,190],"4.72":[189],"ADAS-cog+":[193],"when":[194],"compared":[195],"placebo.":[197],"pilot":[200],"study":[201],"provides":[202,235],"valuable":[203],"estimates":[207],"currently":[216],"being":[217],"confirmed":[218],"larger":[221],"clinical":[222],"trial.":[223],"Due":[224],"sample":[231],"size,":[232],"insufficient":[236],"evidence":[237],"support":[239],"reject":[241],"AD.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1513401887","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":23},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":23},{"year":2021,"cited_by_count":31},{"year":2020,"cited_by_count":47},{"year":2019,"cited_by_count":24},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":34},{"year":2016,"cited_by_count":18},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":28},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
